Why Pacific Biosciences of California, Inc. (PACB) stock fell 6.7% on Wednesday, November 11, 2026

Pacific Biosciences of California, Inc. (PACB) closed at $2.09, down 6.70% on Wednesday, November 11, 2026, on volume of 10,655,192 shares (0.9× its 3-month average); market value about $600.0M, according to Nexqual market data (nexqual.com/moves/2026-11-11/PACB).

What happened: primary sources

Events Nexqual found for PACB on Wednesday, November 11, 2026 or the trading day before (November 10, 2026), each linked to its primary source:

These are listed as context. A filing or rating change on the same day is not proof that it caused the move; read the source.

More on PACB

PACB stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. Other big moves that day: November 11, 2026.

Sources: SEC EDGAR, Nexqual Earnings Flash, analyst rating changes, Nexqual market data. Built November 18, 2026 at 20:53 UTC. Not investment advice.

Data source: Nexqual. Last updated: November 18, 2026 at 20:53 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt